Researchers found different outcomes on the advancement of breast cancer on comparing four types of progestins used in hormone replacement therapies.

Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer.

But it is now that theUniversity …

Read Original Story

Categories: Features, Medical
Tags: